by rss feed | Oct 9, 2020 | 293T cells, COVID-19, Embryonic stem cells, Lawrence Goldstein, News Feeds, Regeneron, Regeneron stem cells, Regeneron Trump stem cells, stem cell politics, Stem cells for COVID-19, Trump COVID-19, Trump stem cells, Trump stem cells COVID-19, What are 293 cells?
Are Trump and the Republican Party showing major hypocrisy over Trump’s use of experimental COVID-19 therapies in part developed by Regeneron using embryonic and fetal cells? The Internet is kind of blowing up over this. Trump’s collision with stem cells...
by rss feed | Oct 4, 2020 | 3D chromatin, COVID-19, Ephron Rosenzweig, Genna Reed, Jacob Koffler, Karen Moxon, Kelly Servick, Mark Tuszynski, misconduct, Myc, News Feeds, Paolo Macchiarini, Paul Lu, science monopoly, Trump COVID, UC Davis, Weekend Reads
Here are some recommended stem cell and other reads for the week ranging from COVID developments to prosecutors finally catching up with a stem cell surgeon who had many patients die to a list of interesting pubs. Because Trump now has COVID, I wondered on Friday if...
by rss feed | Oct 2, 2020 | celebrities, Celltex, celularity, COVID-19, my cells my choice, News Feeds, Roger Stone stem cells, Rudy Giuliani COVID19, Rudy Giuliani stem cells, stem cells for COVID, Trump COVID-19, Trump stem cells, Trump stem cells COVID-19, US Stem Cell
What a difference one day can make including in the types of questions I’m getting with this one rising to the top: should President Donald Trump get stem cells for his COVID-19? Whether he should or not, will he get them? This is more than a hypothetical as a...
by rss feed | Sep 30, 2020 | Celltex, celularity, COVID-19, FDA COVID-19, GIOSTAR, News Feeds, NK cells COVID-19, Rick Perry, Rudy Giuliani, stem cell clinics, Stem cells for COVID-19, Stemedica
In my view, it seems likely that the FDA has opened a big can of worms by starting to clear the COVID-19 trials and programs of for-profit stem cell clinics and other related firms. OK to Stemedica trial The FDA just approved another such effort, this one by the firm...
